GTLS: Annual Thesis 2025–2026

FY25 revenue $4.26B (+2%); Op income $647M (~flat); EBITDA $625M (-32%); Net income $42M (-81%); EPS $0.33 (vs $4.10 FY24). Q1 FY25 orders $1.32B (+17%), commercial pipeline ~$24B. Backlog mix: LNG ~25%. Net leverage target 2.0-2.5× by year-end FY25.

Key takeaways

• Backlog and order book are healthy; income statement is where the damage shows. Q1 orders $1.32B (+17% YoY) and pipeline ~$24B reflect strong demand across LNG, space exploration, hydrogen vehicle tanks, nuclear, marine. But FY25 EPS collapsed from $4.10 to $0.33 — the gap is non-operating: interest expense from $3.7B debt stack (mostly Howden-related), integration costs, FX, and likely impairment-style charges.
• Operating margin held; that's the key signal. OI $647M vs $647.5M FY24 — flat dollar OI on +2% revenue means operating margin compressed slightly, but the underlying business didn't structurally deteriorate. The NI collapse is below-the-line.
• End-market mix is the bull case. LNG 25% of backlog. Hydrogen + space + nuclear are growing high-single to double-digit. Cryo Tank Solutions (CTS) lower revenue but Specialty Products + Repair/Service/Leasing growing 20%+.
• Net leverage target 2.0-2.5× by FY25 end. Q1 FY25 mgmt reaffirmed this target; achieving it requires ~$300-400M of net debt paydown over the year. FY25 actual cash flow ($203M FCF) suggests this target was challenging — debt $3.74B held roughly flat with FY24's $3.74B.
• Howden integration overhang persists. The 2023 acquisition added scale + breadth but also $4B+ of debt and amortizable intangibles compressing GAAP earnings. Until the amortization burden eases, GAAP EPS will continue to look poor relative to adj/cash measures.

Business

Chart Industries is a global designer/manufacturer of cryogenic and process equipment for energy and industrial gases. Post-Howden acquisition (March 2023), it has four reporting segments:

• Cryo Tank Solutions (CTS): Q1 2025 sales $153M (-4%), adj OI margin 12.7% (+220bp). Bulk and engineered tanks for industrial gas, LNG, energy. Mature segment.
• Heat Transfer Systems (HTS): Q1 sales $267M (+5%), adj OI margin 25.5% (+460bp). Brazed aluminum heat exchangers for LNG, hydrogen, helium liquefaction. The high-margin LNG-leverage segment.
• Specialty Products: Q1 sales $276M (+17%), adj OI margin 18.9% (+560bp), GM 30%+ (first time since 2022). Hydrogen (HLNG vehicle tanks, mobile hydrogen), water treatment, space exploration components, nuclear, biomedical. The growth + new-economy exposure.
• Repair Service & Leasing (RSL): Q1 orders $455M (+36%). Aftermarket service, repair, leasing programs around installed base — recurring annuity revenue.

Howden (acquired March 2023 for $4.4B) added: rotating equipment (compressors, blowers, fans, steam turbines), heat-recovery process gas equipment, and a substantial European customer base. Pre-Howden GTLS was ~$1.6B revenue / $215M EBITDA. Post-Howden it's ~$4.3B / $1.0-1.2B EBITDA — but with a debt stack and amortization burden that compresses GAAP EPS.

Key growth verticals (per management):

• LNG: ~25% of backlog. Heat exchangers, cold boxes, regasification, small-scale LNG. Key customers: hyperscaler LNG operators, US export terminals.
• Hydrogen: HLNG vehicle tanks, mobile hydrogen, liquefaction equipment. Long-cycle but real bookings.
• Space exploration: Cryo equipment for SpaceX, Blue Origin, ULA. Niche but high-margin.
• Nuclear: Heat transfer for SMR + traditional nuclear refurb.
• Marine: LNG bunkering, cryo marine fuel systems.

FY25 financial performance

The pattern post-Howden:

• Revenue stepped up from ~$1.6B (pre-deal) to $4.16B FY24 → $4.26B FY25 — small organic + integration mix.
• Gross margin compressed to 29.2% in FY25 (vs 33.4% FY24) — likely reflects mix toward lower-margin Howden process equipment + tariff/raw material pressure on long-cycle projects priced earlier.
• EBITDA dropped to $625M FY25 vs $917M FY24 — meaningful step down, aligned with margin compression.
• NI collapsed to $42M — the gap from FY24's $219M is interest + intangible amortization + likely some restructuring charge.
• FCF $203M down from $382M FY24, capex moderated to $-90M.

Capital allocation

• Capex: $-90M FY25 (~2.1% of revenue) — moderating from FY23 peak. Light capital intensity for the asset base.
• Dividends: $-27M FY25, on the small preferred dividend program. Common doesn't pay dividends.
• Buybacks: zero. All FCF allocated to debt paydown / liquidity preservation.
• Debt: $3.74B held flat YoY — net leverage target of 2.0-2.5× by year-end was not met (actual closer to 3.0× given EBITDA decline). Working through.
• M&A: post-Howden integration phase, no major transactions in FY25.

FY26 outlook (per Q1 2025 call, 2025-05-01 — no Q4 FY25 detail in source)

The FY25 guide issued at Q1 2025 was for $4.65-$4.85B revenue and $1.18-$1.23B adj EBITDA. Actual revenue $4.26B fell short, which is why this thesis is cautious going into FY26: the order book is good but conversion to revenue + EBITDA has lagged the original cadence.

What to watch for FY26 (per Q1 commentary):

• Backlog conversion velocity — has it accelerated?
• LNG project order timing — any new large LNG awards (US export terminal, hyperscaler offtake)?
• Net leverage progress — is debt paydown on track to 2.0-2.5×?
• Specialty Products + RSL growth holding 15-20%+?

Key risks

• LNG project deferrals: 25% of backlog tied to LNG. Any project deferral by an offtaker (FID slip, regulatory delay, geopolitical shock) compresses revenue conversion.
• Howden integration cost overrun: Three years post-deal, integration costs continue to compress GAAP earnings. Any further restructuring or asset write-down delays the de-leveraging.
• Interest burden: $3.7B debt at floating + fixed mix. Higher-for-longer rates compound interest cost; refinancing windows matter.
• Hydrogen / new-energy demand: Specialty Products growth assumes hydrogen + nuclear + space markets continue funding. If hydrogen FID pace slows, the growth narrative softens.
• Commodity / raw material: Long-cycle equipment priced months/years before delivery; raw material inflation can compress margin on mid-life backlog.
• GAAP-vs-adjusted gap: As long as intangible amortization runs, GAAP EPS will print well below adjusted EPS — equity narrative depends on which lens the market uses.

Bottom line

GTLS FY25 is a "the cash story works, the GAAP story doesn't" year. Operating income held, backlog $24B-pipeline expanded, key niches (LNG, hydrogen, space) growing, but interest burden + Howden amortization compressed reported EPS to $0.33. The thesis going into FY26 hinges on (a) backlog conversion accelerating to bring revenue back into $4.65B+ range, (b) net leverage progress toward 2-2.5×, (c) Specialty Products + RSL maintaining 15-20% growth. If those three hit, the GAAP EPS recovers materially. Until then, the equity trades on adjusted EBITDA + free-cash-flow optics rather than GAAP EPS.

Citations

• Chart Industries Inc. FY25 Form 10-K (filed February 2026, SEC EDGAR).
• Chart Industries Q1 2025 earnings call, 2025-05-01 — backlog detail, segment performance, FY25 guide ($4.65-$4.85B sales / $1.18-$1.23B adj EBITDA).
• Howden acquisition disclosure (closed March 2023, $4.4B).
• Internal financial_statements view (consolidated annual + cash flow + debt; reflects integration-period charges).